Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Debt to Equity (2022 - 2025)

Envoy Medical's Debt to Equity history spans 4 years, with the latest figure at -$0.94 for Q2 2025.

  • On a quarterly basis, Debt to Equity fell 364.03% to -$0.94 in Q2 2025 year-over-year; TTM through Jun 2025 was -$0.94, a 364.03% decrease, with the full-year FY2024 number at -$0.5, down 182.89% from a year prior.
  • Debt to Equity hit -$0.94 in Q2 2025 for Envoy Medical, up from -$0.95 in the prior quarter.
  • Over the last five years, Debt to Equity for COCH hit a ceiling of $0.05 in Q3 2023 and a floor of -$0.95 in Q1 2025.
  • Historically, Debt to Equity has averaged -$0.44 across 4 years, with a median of -$0.35 in 2024.
  • Biggest five-year swings in Debt to Equity: crashed 1792.0% in 2023 and later crashed 182.89% in 2024.
  • Tracing COCH's Debt to Equity over 4 years: stood at -$0.01 in 2022, then crashed by 1792.0% to -$0.18 in 2023, then tumbled by 182.89% to -$0.5 in 2024, then plummeted by 88.84% to -$0.94 in 2025.
  • Business Quant data shows Debt to Equity for COCH at -$0.94 in Q2 2025, -$0.95 in Q1 2025, and -$0.5 in Q4 2024.